News

Throug this collaboration, Complete Genomics will use its DNA sequencing technology to sequence five genomes from samples provided by the Broad Institute. The first genome sequenced will be

The Phase II, double blind, vehicle-controlled cross-over study is designed to determine the anti-pruritic efficacy, safety and local dermal toleration of SRD174 cream in patients with atopic dermatitis.

As CFO at JDSU Corp, he designed and implemented restructuring plans for the company’s Asia Pacific organization. Ede has served as a director on Mindray’s board since the

Dr Jay is the managing partner of the Medical Solutions Fund of Siemens Venture Capital, the venture organization for Siemens. Prior to joining Siemens Venture Capital, Dr Jay

As president of Integra NeuroSciences, Mr Thatcher will be responsible for the management of Integra’s foundational division and provide the strategic direction and leadership required to expand the

For the last three years, Mr Sweet served as vice president of marketing and sales for Celerus Diagnostics where he created a sales, marketing and customer care team

Under the terms of the agreements, Pfizer has acquired rights to 39 generic solid oral dose products in the US and 20 in Europe, plus an additional 11

This patent stems from a provisional patent application filed with the US Patent and Trademark Office in February 2004 by Quick-Med. The new patent, together with a previously

Highlights for Fourth Quarter and Full Year 2008 Full year 2008 revenue generated in China and international markets up 61.1% and 110.4%, respectively, over 2007 to a total